We use cookies to help provide you with the best possible online experience.
By using this site, you agree that we may store and access cookies on your device. Cookie policy.
Cookie settings.
Functional Cookies
Functional Cookies are enabled by default at all times so that we can save your preferences for cookie settings and ensure site works and delivers best experience.
3rd Party Cookies
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Teaching and Research
Teaching and Training
We are approved by the London Deanery as a training practice for qualified doctors pursuing a future career in General Practice. We have a number of specialist trainees working within the practice at any one time. Trainees are fully qualified doctors who have completed a number of years working as hospital doctors. Specialist trainees usually spend a minimum of 6 months attached to the practice. We believe that our doctors can continue to develop and learn whatever stage of their career. You may sometimes notice a GP observing the clinic of another GP. This is quite normal and something we encourage for all of our doctors at least twice a year.
Research
The Abbey Medical Centre is a member of NOCLOR, a network of GP practices involved in research. We are currently participating in the following research studies:
The SUMMIT study
What is the purpose of this research?
The SUMMIT study is running across all of North and East London GP Practices. A lot of practices are already involved but more practices are needed in Camden CCG.
The aim is to detect lung cancer early using the proven method of low-dose CT (LDCT) screening of at-risk individuals and support the development of a new blood test for the early detection of lung and other cancers.
50,000 people aged 50-77 living in North and East London will be involved as 2 groups of patients; Group A will be people who currently smoke or have smoked regularly in the past, Group B will be those who do not have significant smoking histories.
RCT of a digital CBT app for smoking cessation
What is the purpose of this research?
Smoking is by far the largest preventable cause of morbidity and mortality worldwide, and is responsible for approximately 80% of deaths resulting from progressive and debilitating diseases including chronic obstructive pulmonary disease (COPD) and cancer. It is estimated that 96,000 people in the UK die every year from smoking-related causes, with the majority being attributed to smoking-related cancer. Given the scale of this problem, the NHS recently pledged “hard-hitting national action” against smoking to align with their focus on disease prevention, and saw the commitment by many NHS Trusts by signing the NHS Statement of Support for Tobacco Control. However, current smoking cessation strategies are failing.
The aim of the study is to investigate the effectiveness of a smart phone-enabled, gamified digital CBT intervention for smoking cessation, measured as the self-reported 4-week success rate. Secondary outcomes are the quit rates at 6- and 12-months after starting the study as well as quality of life, self-efficacy with respect to smoking abstinence, and mental wellbeing.
YouScreen Research Study
From January 2021, a number of GP practices across north and east London will be taking part in the YouScreen study. YouScreen is a research study that will offer 31,000 women and people with a cervix in north and east London the opportunity to take a self-sample for cervical screening.
